Related content

Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson’s patients

By Stocchi F.   Barbato L.   Nordera G.   Bolner A.   Caraceni T.  

Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. : 173-180

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial

By Tolosa Eduardo   Hernández Basilio   Linazasoro Gurutz   López-Lozano Juan   Mir Pablo   Marey José   Kulisevsky Jaime  

Journal of Neural Transmission, Vol. 121, Iss. 4, 2014-04 ,pp. : 357-366

Springer Publishing Company

Access to resources Recommend Favorite

Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease

By Cáceres-Redondo María   Carrillo Fátima   Lama María   Huertas-Fernández Ismael   Vargas-González Laura   Carballo Manuel   Mir Pablo  

Journal of Neurology, Vol. 261, Iss. 3, 2014-03 ,pp. : 561-569

Springer Publishing Company

Access to resources Recommend Favorite

Acute levodopa administration reduces cortisol release in patients with Parkinson’s disease

By Müller T.   Welnic J.   Muhlack S.  

Journal of Neural Transmission, Vol. 114, Iss. 3, 2007-03 ,pp. : 347-350

Springer Publishing Company

Access to resources Recommend Favorite

The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson’s disease

By Lemieux Sarah   Ghassemi Mehrdad   Jog Mandar   Edwards Roderick   Duval Christian  

Experimental Brain Research, Vol. 176, Iss. 3, 2007-01 ,pp. : 465-475

Springer Publishing Company

Access to resources Recommend Favorite